
Sino Biological Inc. — Investor Relations & Filings
Sino Biological Inc. is a global provider of biological reagents and contract research services, specializing in recombinant protein and antibody technologies. The company maintains an extensive catalog of off-the-shelf products, including thousands of recombinant proteins, cytokines, viral antigens, and monoclonal antibodies. These resources support diverse applications in drug discovery, diagnostic development, and basic life science research. Beyond its product portfolio, the company offers comprehensive CRO services such as custom protein expression, antibody development, and biological testing. Utilizing high-throughput mammalian and insect cell expression platforms, Sino Biological provides scalable solutions for the pharmaceutical and biotechnology sectors. The organization is particularly noted for its rapid reagent development in response to emerging infectious diseases and its integrated approach to supporting the global research community.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 非经营性资金占用及其他关联资金往来的专项说明 | 2026-04-13 | Chinese | |
| 关于控股股东部分股份质押的公告 | 2026-03-20 | Chinese | |
| 关于全资子公司通过高新技术企业认定的公告 | 2026-03-02 | Chinese | |
| 关于控股股东部分股份质押的公告 | 2025-12-23 | Chinese | |
| 关于完成工商变更登记并换发营业执照的公告 | 2025-12-12 | Chinese | |
| 关于控股股东部分股份解除质押的公告 | 2025-12-09 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 44561970 | 非经营性资金占用及其他关联资金往来的专项说明 | 2026-04-13 | Chinese | ||
| 44561961 | 关于控股股东部分股份质押的公告 | 2026-03-20 | Chinese | ||
| 44561951 | 关于全资子公司通过高新技术企业认定的公告 | 2026-03-02 | Chinese | ||
|
2025
12 filings
| |||||
| 44561946 | 关于控股股东部分股份质押的公告 | 2025-12-23 | Chinese | ||
| 44561944 | 关于完成工商变更登记并换发营业执照的公告 | 2025-12-12 | Chinese | ||
| 44561933 | 关于控股股东部分股份解除质押的公告 | 2025-12-09 | Chinese | ||
| 44561929 | 第三届董事会第一次会议决议公告 | 2025-12-04 | Chinese | ||
| 44561921 | 关于董事会完成换届选举及聘任高级管理人员、证券事务代表的公告 | 2025-12-04 | Chinese | ||
| 44561905 | 北京市金杜律师事务所关于北京义翘神州科技股份有限公司2025年第二次临时股东大会的法律意见书 | 2025-12-04 | Chinese | ||
| 44561885 | 2025年第二次临时股东大会决议公告 | 2025-12-04 | Chinese | ||
| 44561870 | 关于选举职工代表董事的公告 | 2025-12-04 | Chinese | ||
| 44561861 | 关于控股股东部分股份质押的公告 | 2025-11-27 | Chinese | ||
| 44561846 | 关于独立董事取得独立董事资格证书的公告 | 2025-11-25 | Chinese | ||
| 44561833 | 独立董事候选人关于参加独立董事培训并取得独立董事资格证书的承诺书(郑瑞茂) | 2025-11-18 | Chinese | ||
| 44561830 | 独立董事提名人声明与承诺(尤勇) | 2025-11-18 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Sino Biological Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56004/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56004 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56004 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56004 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56004}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sino Biological Inc. (id: 56004)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.